Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb;34(1):41-50.
doi: 10.1111/fcp.12505. Epub 2019 Oct 28.

NRF2/ABCB1-mediated efflux and PARP1-mediated dampening of DNA damage contribute to doxorubicin resistance in chronic hypoxic HepG2 cells

Xiangwen Xia  1 , Qi Wang  1 , Tianhe Ye  1 , Yiming Liu  1 , Dehan Liu  1 , Songlin Song  1 , Chuansheng Zheng  1
Affiliations

NRF2/ABCB1-mediated efflux and PARP1-mediated dampening of DNA damage contribute to doxorubicin resistance in chronic hypoxic HepG2 cells

Xiangwen Xia et al. Fundam Clin Pharmacol. 2020 Feb.

Abstract

Transarterial chemoembolization (TACE)-induced hypoxia can trigger residual liver cancer cells to present a more aggressive phenotype associated with chemoresistance, but the underlying mechanisms are still unknown. In this study, the human liver cancer cell line HepG2 was pre-cultured in different oxygen environments to examine the possible mechanisms of hypoxia-induced doxorubicin resistance. Our study showed that HepG2 cells pre-cultured in a chronic intermittent hypoxic environment exhibited significant resistance to doxorubicin, evidenced by increased intracellular doxorubicin efflux, relatively higher cell proliferation, lower apoptosis, and decreased DNA damage. These changes were accompanied by high levels of NRF2 and ABCB1 under conditions of both chronic and acute hypoxia and PARP1 gene expression only under conditions of chronic hypoxia. SiRNA-mediated silencing of NRF2 gene expression downregulated the expression of ABCB1 and increased the intracellular doxorubicin accumulation and cell apoptosis both in acute and chronic hypoxic HepG2 cells. Moreover, silencing of PARP1 gene expression increased the doxorubicin-induced DNA damage and cell apoptosis in chronic hypoxic cells. On the basis of these findings, we concluded that NRF2/ABCB1-mediated efflux and PARP1-mediated DNA repair contribute to doxorubicin resistance in chronic hypoxic HepG2 cells.

Keywords: DNA damage; apoptosis; chemoresistance; doxorubicin; efflux; hypoxia.

PubMed Disclaimer

References

    1. Savic L.J., Chapiro J., Geschwind J.F. Science to practice: killing dormant cells-is targeting autophagy the key to complete tumor response in transarterial chemoembolization? Radiology (2017) 283 621-623.
    1. Pinato D.J., Pai M., Reccia I. et al. Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma. BMC Cancer (2018) 18 211.
    1. de Baere T., Arai Y., Lencioni R. et al. Treatment of liver tumors with Lipiodol TACE: technical recommendations from experts opinion. Cardiovasc. Intervent. Radiol. (2016) 39 334-343.
    1. Liang B., Zheng C., Feng G. et al. Experimental evaluation of inhibitory effect of 10-hydroxycamptothecin on hypoxia-inducible factor-1alpha expression and angiogenesis in liver tumors after transcatheter arterial embolization. J. Vascular Interv. Radiol. (2010) 21 1565-1572.
    1. Liu Y., Xia X., Wang Y. et al. Screening and identification of a specific peptide for targeting hypoxic hepatoma cells. Mol. Cell. Probes (2016) 30 246-253.

MeSH terms

Associated data

LinkOut - more resources